Top section
Top section
◆ Have capital markets comprehended the heatwave? ◆ Which SSA issuers need to get it done this autumn ◆ Halcyon days for MTN, M&A and ECM bankers
Investors pay little heed to alarming worsening of climate
New $75m partnership to develop treatment for lymphoma was “catalyst for investors”
More articles
More articles
More articles
-
Finablr has set a range on its London IPO, valuing the business at a more conservative multiple than many had expected when the roadshow began. That will please prospective buyers, some of whom were also impressed with an appearance from the company’s billionaire owner, BR Shetty. -
BASF’s oil and gas unit Wintershall and rival DEA have completed their merger, creating the largest independent oil and gas company in Europe, paving the way for a blockbuster IPO on the Frankfurt Stock Exchange in 2020.
-
Viva Biotech Holdings has pulled off an impressive HK$1.52bn ($194m) Hong Kong IPO, striking retail gold as the local public swamped the deal, grabbing half of the stock for themselves. The high level of retail interest is a rarity for IPOs in the city and something that is often unwanted, bringing potential wild price swings to a stock soon after listing, say some bankers. But others foresee enough institutional demand to swallow any bulk selling in the first days of trading. Jonathan Breen reports.
-
Duiba Group raised $667m after concluding its second attempt at listing on the Hong Kong Stock Exchange.
-
The Securities & Exchange Board of India (Sebi) dealt a fresh blow to India’s National Stock Exchange’s long-delayed IPO plans this week.
-
Software company Kingsoft Corp plans to spin off and list Beijing Office Software on Shanghai’s new technology board, pulling its initial plan to float the subsidiary on the Shenzhen Stock Exchange’s junior ChiNext board.
Sub-sections
shared comment list
